Skip to main content
Clinical Trials/NCT02716909
NCT02716909
Completed
Phase 3

Pessary in Singleton Gestations With Short Cervix Without Prior Preterm Birth

Federico II University1 site in 1 country300 target enrollmentMarch 2016
ConditionsPreterm Birth

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Preterm Birth
Sponsor
Federico II University
Enrollment
300
Locations
1
Primary Endpoint
Spontaneous preterm birth (SPTB) <34 weeks
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

Spontaneous preterm birth (SPTB) remains the number one cause of perinatal mortality in many countries, including the United States. In singleton gestations a short cervical length (CL) on transvaginal ultrasound (TVU) has been shown to be a good predictor of SPTB.

The cervical pessary is a silicone device that has been used to prevent SPTB. The efficacy of cervical pessary has been assessed in several populations including singletons with short CL, unselected twins, twins with a short CL, and triplet pregnancies. Several randomized clinical trials (RCTs) have been published, and several are ongoing. However, no consensus on the use of cervical pessary in pregnancy or guidelines for management have been assessed.

Registry
clinicaltrials.gov
Start Date
March 2016
End Date
July 2017
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Federico II University
Responsible Party
Principal Investigator
Principal Investigator

Gabriele Saccone

Medical Doctor

Federico II University

Eligibility Criteria

Inclusion Criteria

  • 18-50 years of age
  • Singleton pregnancy (limits the participants to female gender)
  • Short cervical length (less than or equal to 25 mm) on second trimester transvaginal ultrasound at 18-23 6/7 weeks gestation

Exclusion Criteria

  • Multiple gestation
  • Prior spontaneous preterm birth 16-36 6/7 weeks
  • Ruptured membranes
  • Lethal fetal structural anomaly
  • Fetal chromosomal abnormality
  • Cerclage in place (or planned placement)
  • Vaginal bleeding
  • Suspicion of chorioamnionitis
  • Ballooning of membranes outside the cervix into the vagina or CL = 0 mm on transvaginal ultrasound
  • Painful regular uterine contractions

Outcomes

Primary Outcomes

Spontaneous preterm birth (SPTB) <34 weeks

Time Frame: Less than 34 weeks gestation

Spontaneous preterm delivery less than 34 weeks of gestation

Secondary Outcomes

  • preterm premature rupture of membranes(Less than 34 weeks gestation)
  • Latency(time of delivery)
  • SPTB <37w(Less than 37 weeks gestation)
  • SPTB <32w(Less than 32 weeks gestation)
  • SPTB <28w(Less than 32 weeks gestation)
  • Gestational age at delivery(Time of delivery)
  • Type of delivery(time of delivery)
  • Maternal side effects(Time of delivery)
  • Birth weight(Time of delivery)
  • Neonatal death(Between birth and 28 days of age)
  • perinatal death(fetal death after 20 weeks)
  • Composite adverse perinatal outcome(Between birth and 28 days of age)
  • Chorioamnionitis(Time of delivery)
  • Adminssion to neonatal intensive care unit(Between birth and 28 days of age)

Study Sites (1)

Loading locations...

Similar Trials